These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7506113)

  • 1. Selective agonists at NK3 tachykinin receptors inhibit alcohol intake in Sardinian alcohol-preferring rats.
    Ciccocioppo R; Panocka I; Pompei P; De Caro G; Massi M
    Brain Res Bull; 1994; 33(1):71-7. PubMed ID: 7506113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of isotonic sodium chloride intake in the rat by selective tachykinin agonists.
    Ciccocioppo R; Polidori C; Pompei P; de Caro G; Massi M
    Pharmacol Biochem Behav; 1994 Mar; 47(3):609-15. PubMed ID: 8208781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
    Broccardo M; Improta G; Tabacco A
    Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of tachykinin NK-3 receptors in the nucleus basalis magnocellularis reduces alcohol intake in rats.
    Ciccocioppo R; Panocka I; Polidori C; De Caro G; Regoli D; Massi M
    Peptides; 1997; 18(9):1349-55. PubMed ID: 9392836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tachykinin NH2-senktide inhibits alcohol intake in alcohol-preferring rats.
    Perfumi M; Polidori C; Pompei PL; De Caro G; Massi M
    Pharmacol Biochem Behav; 1991 Apr; 38(4):881-7. PubMed ID: 1714609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous injections of the tachykinin senktide reduce alcohol intake in alcohol-preferring rats.
    Ciccocioppo R; Panocka I; Pompei P; Polidori C; de Caro G; Massi M
    Peptides; 1995; 16(3):533-7. PubMed ID: 7544465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence that the tachykinin PG-KII is a potent agonist at central NK-3, but not NK-1, receptors.
    Polidori C; Panocka I; Ciccocioppo R; Broccardo M; Improta G; Regoli D; Massi M
    Peptides; 1997; 18(6):825-33. PubMed ID: 9285931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contractile effect of tachykinins on Suncus murinus (house musk shrew) isolated ileum.
    Cheng FH; Chan SW; Rudd JA
    Neuropeptides; 2008; 42(5-6):671-9. PubMed ID: 18582934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of brain sites to the inhibitory effect on alcohol intake of the tachykinin aminosenktide.
    Panocka I; Ciccocioppo R; Polidori C; Angeletti S; De Caro G; Massi M
    Peptides; 1998; 19(5):897-905. PubMed ID: 9663456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular injections of tachykinin NK3 receptor agonists suppress the intake of "salty" tastes by sodium deficient rats.
    Flynn FW
    Behav Brain Res; 2006 Jan; 166(1):1-8. PubMed ID: 16154648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of taste reactivity to study the mechanism of alcohol intake inhibition by the tachykinin aminosenktide.
    Polidori C; Recchi S; Venturi F; Ciccocioppo R; Massi M
    Peptides; 1998; 19(9):1557-64. PubMed ID: 9864063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
    Fisher L; Pennefather JN
    Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
    Picard P; Chrétien L; Couture R
    Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
    Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
    Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonists selective for tachykinin NK1 and NK3 receptors excite subpopulations of neurons in the rat medial habenula nucleus in vitro.
    Norris SK; Boden PR; Woodruff GN
    Eur J Pharmacol; 1993 Apr; 234(2-3):223-8. PubMed ID: 7683268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.